Haleon (HLN) EBITDA (2021 - 2023)

Haleon (HLN) posted EBITDA of $2.1 billion for Q4 2023, up 232.86% on a QoQ basis from $643.2 million in Q2 2023, and up 24.26% year-over-year from $1.7 billion in Q4 2022.

Haleon (HLN) EBITDA (2021 - 2023) Analysis & Trends

Haleon's EBITDA history runs 3 years deep, the most recent figure standing at $2.1 billion for Q4 2023.

  • Quarterly EBITDA rose 24.26% year-over-year to $2.1 billion in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $5.3 billion (changed N/A YoY) and the FY2025 annual result came in at $3.2 billion, down 11.3% from the prior year.
  • EBITDA was $2.1 billion for Q4 2023 at Haleon, up from $643.2 million in the prior quarter.
  • Across five years, EBITDA topped out at $2.1 billion in Q4 2023 and bottomed at $643.2 million in Q2 2023.
  • A 3-year average of $1.3 billion and a median of $1.4 billion in 2021 frame the typical range for EBITDA.
  • Annual changes were most pronounced in 2022 — EBITDA gained 2.75% — and 2023, when it gained 24.26%.
  • Haleon's EBITDA stood at $1.7 billion in 2021, then rose by 2.75% to $1.7 billion in 2022, then rose by 24.26% to $2.1 billion in 2023.
  • Business Quant data shows HLN's EBITDA at $2.1 billion in Q4 2023, $643.2 million in Q2 2023, and $766.7 million in Q2 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Haleon 88.07 Bn 86.20 Bn - -
2 Teva Pharmaceutical Industries 35.75 Bn 32.01 Bn 1.97 Bn 652.00 Mn
3 Zoetis 31.84 Bn 29.90 Bn 1.62 Bn 833.00 Mn
4 Takeda Pharmaceutical 27.18 Bn 23.12 Bn 4.39 Bn -2.65 Bn
5 United Therapeutics 23.09 Bn 20.93 Bn 648.10 Mn 325.80 Mn
6 RedHill Biopharma 21.32 Bn 21.32 Bn - -
7 Viatris 19.96 Bn 18.16 Bn 1.16 Bn -79.70 Mn
8 Neurocrine Biosciences 17.66 Bn 16.34 Bn 800.70 Mn 193.40 Mn
9 Elanco Animal Health 12.44 Bn 12.02 Bn 785.00 Mn 291.00 Mn
10 Vireo Growth 10.53 Bn 10.38 Bn 59.30 Mn 9.00 Mn

Historic Data

Download Data
DateValue
Dec 31, 2023 2.14 Bn
Jun 30, 2023 643.20 Mn
May 3, 2023 766.68 Mn
Dec 31, 2022 1.72 Bn
Sep 20, 2022 1.11 Bn
Dec 31, 2021 1.68 Bn